clinical-decision-support
(4)
Dan Cornwell
Dan Cornwell is the founder and CEO of PrescriberPoint, a Boston-based, AI-enabled medication access platform that helps clinicians cut through the paperwork between writing a prescription and a patient actually getting their medicine. Spun out of Eli Lilly in partnership with BCG Digital Ventures, the company raised seed backing from an unusual coalition of would-be rivals - Lilly, Pfizer, Adobe and Mastercard. Before PrescriberPoint, Cornwell ran the nurse-staffing marketplace IntelyCare and advised companies on building disruptive businesses at BCG Digital Ventures. A Yale historian turned Wharton-trained operator, he keeps returning to the same problem: the messy gap between a good intention and a completed transaction.
Andrew Le
Andrew Le is the co-founder and CEO of Buoy Health, an AI-driven health navigation platform he started out of Harvard Innovation Labs in 2014 after taking three years off from Harvard Medical School. A physician by training who once researched brain cancer, Le built Buoy to answer one deceptively simple question for people who reach for Google first: when do I actually need to see a doctor? Under his leadership Buoy has raised more than $66 million and reached millions of users, drawing backing from major insurers including Optum, Cigna and Humana.
Anirudh Joshi
Anirudh Joshi is the co-founder and CEO of Valar Labs, a Palo Alto-based AI oncology company building tools that let doctors predict whether a specific cancer treatment will work before a patient wastes months on the wrong one. A biomedical engineer trained at Georgia Tech and Stanford, he previously built AI at Microsoft, PathAI, and Curai before co-founding Valar in 2021 with teammates from Stanford's AI in Medicine group. Valar raised $26M total, landing a $22M Series A from Andreessen Horowitz and DCVC in 2024, and its flagship test Vesta — predicting BCG therapy response in bladder cancer — is now live at 20 U.S. hospitals. Named to Forbes 30 Under 30 Healthcare 2025.
Nishith Khandwala
Nishith Khandwala (Nish) is the co-founder and CEO of Bunkerhill Health, a San Francisco-based AI company building the operating system for clinical action inside health systems. A Stanford computer scientist who started in AI labs with no healthcare background, he pivoted after physicians walked in with real clinical problems - and after his own father's heart attack forced him to ask why his coronary calcium AI wasn't reaching patients. Bunkerhill's Carebricks platform now powers 7+ clinical domains at major health systems including UTMB, HCA Florida, MedStar, and WVU Medicine. The company has raised $30.4M from Sequoia, Optum Ventures, and Y Combinator, earned multiple FDA clearances, and landed Nishith on Forbes 30 Under 30 and the inaugural Mayfield Divot AI List.